This research allowed us to study the features of the of p16INK4a/Ki-67 dual biomarker expression in the cervical cytological screening material and compare the accuracy of the immunocytochemical methodology and the Pap test in detecting high-grade dysplasia of the cervix. This evidence concerns the gene CDKN2A and dysplasia.